The Faber Report

FABER REPORT VIDEO

» More

- Faber Report: IPO Performance 10 Feb 2012
  CNBC's David Faber takes a look at recent IPOs that have had a run in the market, including LinkedIn and Caesars.
- Faber Report: Media Spending Bucks on Buybacks 09 Feb 2012
  CNBC's David Faber takes a look at how media companies are spending their cash.
- Faber Report: Diamond Foods Accounting 09 Feb 2012
  CNBC's David Faber and Herb Greenberg have the details on the ongoing investigation on Diamond Foods accounting practices.
- Faber Report: HCA Holdings' Special Dividends 06 Feb 2012
  CNBC's David Faber has a look at HCA Holdings a year after its sponsor-led IPO and its announcement to pay special dividends.
- Faber Report: Little Caesars IPO Details 03 Feb 2012
  CNBC's David Faber has the story on Little Caesars IPO, expected to price between $8-$10 per share.
- Faber Report: Viacom Earnings 02 Feb 2012
  CNBC's David Faber takes a look at Viacom's Q1 revenue, up in networks and film segments compared to last year.

RSS FEED

» Help

Subscribe to this RSS feed
Stay up to date with The Faber Report.

COMMUNITY

Twitter
Follow The Strategy Session and The Faber Report on Twitter.

Warner Chilcott's Special Cash Dividend

Published: Friday, 30 Jul 2010 | 12:32 PM ET

Text Size

By: Reported by David Faber, written by Gennine Kelly

Warner Chilcott, a leading specialty pharmaceutical company in North America and Western Europe, announced today a special cash dividend of $8.50 per share.

This means $2.25 billion of new debt will be used to fund a special dividend to shareholders— approximately $2.15 billion in the aggregate.

The new debt is expected to be comprised of a combination of senior secured-term loans and additional unsecured debt.

Warner [WCRX Loading... () ] is a product of a leveraged buyout (LBO)—it does trade, but is still owned, in part, by private equity. Perhaps this is the reason for the significant size of the leverage recap.

The company expects to declare and pay the special cash dividend before the end of the third quarter of 2010.

_____________________________

More from The Faber Report:

thefaberreport.cnbc.com and now on Twitter @DAVIDFABER_CNBC

Questions? Comments? Write to .

Sectors:Pharmaceuticals and Biotechnology | Pharmaceuticals | Financial Services

Companies:Warner Chilcott Limited

Print Email

The Faber Report

RECENT POSTS

FABER REPORT VIDEO

RSS FEED

COMMUNITY

RECENT POSTS: THE STRATEGY SESSION

Warner Chilcott's Special Cash Dividend